Exelixis (EXEL) Capital Expenditures Growth (1y) (2011 - 2026)
Exelixis (EXEL) Capital Expenditures Growth (1y) (2011 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
- |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
227.76% |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
Exelixis |
13.71 Bn |
12.93 Bn |
590.86 Mn |
-48.88% |
| Date | Value |
|---|
| Apr 3, 2026 |
-48.88% |
| Jan 2, 2026 |
-70.91% |
| Oct 3, 2025 |
-81.92% |
| Jul 4, 2025 |
-56.80% |
| Apr 4, 2025 |
-69.54% |
| Jan 3, 2025 |
-69.72% |
| Sep 27, 2024 |
-12.55% |
| Jun 28, 2024 |
10.66% |
| Mar 29, 2024 |
-19.40% |
| Dec 29, 2023 |
35.18% |
| Sep 29, 2023 |
85.86% |
| Jun 30, 2023 |
-19.08% |
| Mar 31, 2023 |
114.37% |
| Dec 30, 2022 |
63.04% |
| Sep 30, 2022 |
-88.31% |
| Jul 1, 2022 |
187.01% |
| Apr 1, 2022 |
-58.63% |
| Dec 31, 2021 |
-80.26% |
| Apr 2, 2021 |
357.85% |
| Apr 3, 2020 |
2,000.00% |
